(Q37740291)

22 August 2017

1 reference

title

Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score (English)

1 reference

22 August 2017

0 references

0 references

Gregory C Connolly

1

1 reference

PubMed ID

20433985

22 August 2017

Alok A Khorana

series ordinal

2

1 reference

22 August 2017

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

125 Suppl 2

1 reference

22 August 2017

S1-7

1 reference

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence of venous thromboembolism in patients hospitalized with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Prognosis of Cancers Associated with Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence of venous thromboembolism and its effect on survival among patients with common cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Thromboembolism in hospitalized neutropenic cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

The incidence of venous thromboembolism among patients with primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Development and validation of a predictive model for chemotherapy-associated thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Risk factors for venous thromboembolic events in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence of venous thromboembolism and the impact on survival in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Venous thromboembolism in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Venous thromboembolism in patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Ovarian cancer and venous thromboembolic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Perioperative complications of radical cystectomy in a contemporary series.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence of venous thromboembolism in patients undergoing craniotomy and motor mapping for glioma without intraoperative mechanical prophylaxis to the contralateral leg

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Epidemiology of venous thromboembolism in 9489 patients with malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Silent venous thromboembolism before treatment in endometrial cancer and the risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Assessing risk of venous thromboembolism in the patient with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Increased risk of venous thromboembolism in patients with acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Postoperative complications of lung transplantation: radiologic findings along a time continuum.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Deep Venous Thromboembolism in Patients Undergoing Inguinal Lymph Node Dissection for Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

High incidence of silent venous thromboembolism before treatment in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer center

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Phase II trial of fenretinide in advanced renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Thromboembolism in children with sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Venous thromboembolism in patients with primary bone or soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Risk factors associated with venous thromboembolic events in patients with malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Erythropoietin or Darbepoetin for patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Associations between white blood cell count and risk for cerebrovascular disease mortality: NHANES II Mortality Study, 1976-1992

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Gr

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2900227-6

7 January 2021

10.1016/S0049-3848(10)00227-6

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20433985